Preora Healthcare

Executive Summary

Preora Healthcare is a San Diego-based diagnostics company developing non-invasive breath analysis technology for early disease detection. Founded in 2018, the company leverages volatile organic compound (VOC) biomarkers to create rapid, patient-friendly screening and monitoring tests. Its platform aims to transform the diagnostic paradigm by enabling point-of-care or at-home detection of conditions such as cancer, infectious diseases, or metabolic disorders, potentially reducing the need for invasive biopsies and expensive imaging. Although still in early development with no disclosed funding or clinical milestones, Preora’s approach addresses a growing market demand for accessible, low-cost screening tools. The company’s intellectual property around VOC signatures and breath collection methods could offer a competitive edge, but validation through clinical studies and regulatory clearance remains the critical near-term hurdle.

Upcoming Catalysts (preview)

• Q3 2026Series A funding round or grant announcement60% success
• TBDFDA Breakthrough Device Designation for lead indication40% success
• Q4 2026Clinical feasibility study results publication50% success